Home/Filings/4/0001144204-15-019403
4//SEC Filing

NAVIDEA BIOPHARMACEUTICALS, INC. 4

Accession 0001144204-15-019403

CIK 0000810509operating

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 4:33 PM ET

Size

5.3 KB

Accession

0001144204-15-019403

Insider Transaction Report

Form 4
Period: 2015-03-26
Regan William J.
SVP of lobal Regulatory Strate
Transactions
  • Award

    Common Stock (Right to Buy)

    2015-03-26+165,000165,000 total
    Exercise: $1.65Exp: 2025-03-26Common Stock (165,000 underlying)
Footnotes (1)
  • [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000810509

Filing Metadata

Form type
4
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:33 PM ET
Size
5.3 KB